![]() |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Saturday, November 21, 2009
|


- In the recently publicized Breast Cancer Prevention Trial, the use of Tamoxifen reduced the incidence of invasive cancer for women considered at high risk of developing it. Women with lobular carcinoma in situ were eligible for the study, but women with ductal carcinoma in situ were not. Do you know why?
- I was treated for DCIS with surgery and radiation. Is this a cancer? Do I check "yes" on forms when asked "Have you had breast cancer?" I tried to donate blood. I was told that I had to wait until 5 years after treatment even though my cancer was in situ. Why?
- What is intraductal papilloma cancer? What are the treatments?
- My sister (50 years old, white, generally good health) suffers from fibrocystic disease in her breasts. Her condition (which runs in our family) has been getting worse over the last 2-4 years. Her physician is now talking about a double mastectomy. Just what are her options? If she does not have the surgery, is there any danger of the tumors causing other health problems?
- How often is fibrocystic change malignant?
- What is Paget's Disease and how does it form?
Ductal Carcinoma in situ (DCIS) is a lesion that can become invasive cancer or there are ductal cancer cells that have not grown outside of their site origin. This is the difference between the two types. Women with DCIS were not candidates for the study because they may already have cancer cells or the cells can become cancer, whereas, LCIS cells do not become cancer.
The treatment may depend upon the pattern of the ductal cancer cells. One pattern is called micropapillary which looks like a finger sticking out into the center of the duct. Another pattern is cribriform which looks like punched out holes within the duct. The third pattern is comedo which is like a whitehead pimple that fills the duct. Some cases of DCIS have both the comedo and non-comedo patterns. Mastectomy was the treatment of choice since a cancerous duct may run through and intertwine a large area of the breast. More recently, the surgeon tries to remove the entire duct using a wide excision which also includes a rim of normal breast tissue. Some experts say that when DCIS is present, it is likely that more ducts are precancerous and believe a mastectomy should be the treatment. Studies show that mastectomy treatment gives a lower recurrence rate of cancer. Radiation used along with wide excision proved to have a lower recurrence than those treated with wide excision only. There seems to be a growing belief in using radiation with wide excision for certain cases of DCIS. Other cases need a mastectomy. The patient needs to know and understand the pathology report and discuss these options with the surgeon according to individual history and the extent of DCIS.
There is one breast condition that does suggest increased cancer risk called atypical hyperplasia that has been wrongly termed fibrocystic disease. Atypical hyperplasia are cells in the breast that are abnormal and increased in number. Women with atypical hyperplasia have an increased relative risk of 3.5 for breast cancer. If they have a family history of breast cancer the risk increases to 8-9. A woman who has been told she has atypical hyperplasia should be very committed to close follow-up. This means a yearly mammogram and a physical exam of the breasts every 6 months by a doctor or a certified health worker.
Paget's Disease is diagnosed with a biopsy of the skin. A mammogram must be done to see if the cancer is in the breast as it is sometimes associated with ductal carcinoma. Treatment depends upon the extent of the disease. If the cancer cells are only of the nipple, only the nipple and areola need to be surgically removed. This type is usually slow growing and has not invaded the lymph nodes. Sometimes a wide excision of the area and radiation is done without a mastectomy. If the cancer is invasive and present deeper in the ducts, a mastectomy of the breast is the treatment. The diagnosis of cancer is frightening but Paget's Disease is very treatable.
There are two theories as to the origin of the disease. One is associated with invasive cancer inside the breast. The malignant cells originate in the parenchyma of the breast and migrate along the duct to the nipple epithelium. The other main theory is that the malignancy originates in the epithelium or the cells covering the nipple. The malignant cells arise in the epidermis from multipotent cells (cells that have the ability to become any of several mature cell types) in the basal layer that suggest a transformation of normal epidermal cells into Paget cells.
When any of the above symptoms occur, a mammogram is necessary to the see if cancer is in the breast itself. The skin on the nipple should be biopsied. Under the microscope cancer cells can be seen growing up into the skin of the nipple, which causes the itching, scaling skin. Sometimes Paget's is associated with cancer inside the breast and sometimes it is only on the nipple and areola. Treatment is according to the origin of the disease.
This article is a NetWellness exclusive.
Last Reviewed: Jun 12, 2002
|
Janet Trigg, RN, MSN, EdD Formerly: College of Nursing University of Cincinnati |
|